Minimal access colonic surgery: is it truly minimally invasive?

Area of Science:

• Surgical Innovation
• Inflammatory Response
• Patient Recovery

Background:

• Laparoscopic colonic surgery is used for benign and malignant conditions.
• Proposed benefits include less pain, metabolic disturbance, and faster recovery.
• Pro-inflammatory mediators like cytokines drive metabolic changes post-surgery.

Purpose of the Study:

• To evaluate the metabolic benefits of laparoscopic colorectal surgery.
• To compare inflammatory mediator levels between laparoscopic and open colorectal surgery.
• To determine the impact of wound size on postoperative recovery.

Main Methods:

• Comparison of serum and abdominal drain fluid cytokine levels.
• Analysis of perioperative management protocols.
• Assessment of recovery metrics in patients undergoing laparoscopic versus open colorectal surgery.

Main Results:

• Serum cytokine levels are lower after laparoscopic colorectal surgery than open surgery.
• Abdominal drain fluid cytokine levels are similar regardless of incision size.
• Drain fluid cytokine concentrations significantly exceed serum levels.
• Minimal metabolic benefit observed with laparoscopic colorectal surgery in optimally managed patients.

Conclusions:

• The peritoneal wound, not the skin incision, is the primary driver of metabolic events in major laparoscopic colorectal surgery.
• Minimal access does not always equate to minimal invasion in colorectal procedures.
• The significance of the skin wound diminishes with larger peritoneal defects.